Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 49 Lymphoma 39 Lymphoma, Non-Hodgkin 31 Hodgkin Disease 22 Lymphoma, Follicular 18 Burkitt Lymphoma 17 Lymphoma, Mantle-Cell 15 Leukemia, Lymphocytic, Chronic, B-Cell 15 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Lymphoma, Large-Cell, Immunoblastic 14 Lymphoma, Large-Cell, Anaplastic 14 Lymphoma, B-Cell, Marginal Zone 14 Lymphoma, B-Cell 11 Leukemia, Myeloid, Acute 10 Immunoblastic Lymphadenopathy 9 Waldenstrom Macroglobulinemia 8 Leukemia, Myelomonocytic, Chronic 8 Blast Crisis 8 Recurrence 7 Leukemia, Myeloid, Accelerated Phase 7 Leukemia 7 Dendritic Cell Sarcoma, Interdigitating 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Myelodysplastic Syndromes 6 Leukemia, Myeloid, Chronic-Phase 6 Neuroblastoma 5 Mycosis Fungoides 5 Multiple Myeloma 5 Lymphoma, T-Cell, Peripheral 5 Lymphoma, T-Cell, Cutaneous 5

Interventions

midostaurin 2 selinexor 1 pegfilgrastim 1 glofitamab 1 Topotecan 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Aggression × Carboplatin × Lymphoid × Clear all

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡